Clinical Trial Update: The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes Patients

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating ipragliflozin treatment in elderly patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Suglat (ipragliflozin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Type 2 Diabetes | Status: COMPLETED